UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Investigation of PTC124-mediated translational readthrough in a retinal organoid model of AIPL1-associated Leber congenital amaurosis
  • Publication Type:
    Journal article
  • Authors:
    Leung A, Sacristan-Reviriego A, Perdigão PRL, Sai H, Georgiou M, Kalitzeos A, Carr A-JF, Coffey PJ, Michaelides M, Bainbridge J, Cheetham ME, van der Spuy J
  • Publisher:
    Elsevier BV
  • Publication date:
    08/09/2022
  • Journal:
    Stem Cell Reports
  • Medium:
    Print-Electronic
  • Status:
    Accepted
  • Country:
    United States
  • PII:
    S2213-6711(22)00414-3
  • Language:
    English
  • Keywords:
    CRISPR-Cas9, LCA, Leber congenital amaurosis, ROs, TRID, gene editing, induced pluripotent stem cells, inherited retinal degeneration, renal epithelial cell reprogramming, retinal organoids, translation readthrough-inducing drug
  • Notes:
    © 2022 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Abstract
Leber congenital amaurosis type 4 (LCA4), caused by AIPL1 mutations, is characterized by severe sight impairment in infancy and rapidly progressing degeneration of photoreceptor cells. We generated retinal organoids using induced pluripotent stem cells (iPSCs) from renal epithelial cells obtained from four children with AIPL1 nonsense mutations. iPSC-derived photoreceptors exhibited the molecular hallmarks of LCA4, including undetectable AIPL1 and rod cyclic guanosine monophosphate (cGMP) phosphodiesterase (PDE6) compared with control or CRISPR-corrected organoids. Increased levels of cGMP were detected. The translational readthrough-inducing drug (TRID) PTC124 was investigated as a potential therapeutic agent. LCA4 retinal organoids exhibited low levels of rescue of full-length AIPL1. However, this was insufficient to fully restore PDE6 in photoreceptors and reduce cGMP. LCA4 retinal organoids are a valuable platform for in vitro investigation of novel therapeutic agents.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers Show More
Author
Institute of Ophthalmology
Author
Institute of Ophthalmology
Author
Institute of Ophthalmology
Author
Institute of Ophthalmology
Author
Institute of Ophthalmology
Author
Inst of Clinical Trials &Methodology
Author
Institute of Ophthalmology
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by